Table 3.
NLR | RDW | PLR | ||||
---|---|---|---|---|---|---|
r | P‐value | r | P‐value | r | P‐value | |
IgG | .048 | .484 | −.033 | .628 | .263 | .000* |
IgM | .191 | .092 | .094 | .247 | .112 | .133 |
IgA | .108 | .246 | .118 | .235 | .076 | .338 |
C3 | −.265 | .000* | −.207 | .002* | −.033 | .629 |
C4 | −.033 | .630 | −.196 | .004* | −.015 | .824 |
ESR | .635 | .000* | .124 | .100 | .097 | .242 |
Hs‐CRP | .469 | .000* | .259 | .017* | .193 | .012* |
CAR | .244 | .003* | .248 | .001* | .077 | .318 |
TG | .383 | 0.000* | .326 | .000* | .011 | .884 |
TC | −.062 | .420 | −.015 | .840 | −.083 | 0.275 |
HDL‐C | −.033 | .664 | −.071 | .354 | −.275 | .000* |
LDL‐C | −.237 | .002* | −.012 | .877 | −.051 | .509 |
TP | .039 | .581 | −.257 | .001* | .108 | .127 |
PA | −.132 | .061 | −.131 | .064 | −.144 | .041* |
ALB | −.364 | .000* | –.192 | .006* | −0.028 | .691 |
UA | .374 | .000* | .064 | .363 | −.187 | .008* |
SLEDAI | .346 | .000* | .279 | .000* | .312 | .000* |
Abbreviations: ALB, albumin; C3, complement 3; C4, complement 4; CAR, c‐reactive protein level to albumin level ratio; ESR, erythrocyte sedimentation rate; HDL‐C, high‐density lipoprotein cholesterol; hs‐CRP, hypersensitive c‐reactive protein; IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M; LDL‐C, low‐density lipoprotein cholesterol; PA, prealbumin; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; TC, total cholesterol; TG, triglyceride; TP, total protein; UA, uric acid.
P < .05 was regarded as statistically significant.